On the public citation graph

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis

https://doi.org/10.1371/journal.pone.0252617
0 signed · 290 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.12839openalex-snapshot
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
inferredcites →https://doi.org/10.1002/14651858.cd013652openalex-snapshot
Antibody tests for identification of current and past infection with SARS-CoV-2
inferredcites →https://doi.org/10.1002/14651858.cd013652.pub2openalex-snapshot
Antibody tests for identification of current and past infection with SARS-CoV-2
inferredcites →https://doi.org/10.1002/9780470712184openalex-snapshot
Cochrane Handbook for Systematic Reviews of Interventions
inferredcites →https://doi.org/10.1016/j.amepre.2020.06.005openalex-snapshot
Disparities in COVID-19 Testing and Positivity in New York City
inferredcites →https://doi.org/10.1016/j.cmi.2020.10.020openalex-snapshot
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.eclinm.2020.100404openalex-snapshot
The impact of ethnicity on clinical outcomes in COVID-19: A systematic review
inferredcites →https://doi.org/10.1016/j.lanepe.2021.100098openalex-snapshot
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
inferredcites →https://doi.org/10.1016/s0140-6736(21)00634-6openalex-snapshot
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
inferredcites →https://doi.org/10.1016/s1473-3099(20)30287-5openalex-snapshot
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
inferredcites →https://doi.org/10.1016/s1473-3099(20)30631-9openalex-snapshot
SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
inferredcites →https://doi.org/10.1016/s1473-3099(20)30833-1openalex-snapshot
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study
inferredcites →https://doi.org/10.1016/s2214-109x(21)00026-7openalex-snapshot
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/s2666-7568(20)30016-7openalex-snapshot
Residential context and COVID-19 mortality among adults aged 70 years and older in Stockholm: a population-based, observational study using individual-level data
inferredcites →https://doi.org/10.1093/infdis/jiaa796openalex-snapshot
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline
inferredcites →https://doi.org/10.1093/intqhc/mzaa113openalex-snapshot
The 40 health systems, COVID-19 (40HS, C-19) study
inferredcites →https://doi.org/10.1097/sr9.0000000000000007openalex-snapshot
COVID-19: a review
inferredcites →https://doi.org/10.1097/xeb.0000000000000054openalex-snapshot
Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data
inferredcites →https://doi.org/10.1101/2020.05.10.20097451openalex-snapshot
Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys
inferredcites →https://doi.org/10.1101/2020.05.16.20104117openalex-snapshot
Pitfalls and solutions in case fatality risk estimation – A multi-country analysis on the role of demographics, surveillance, time lags between reporting and death and healthcare system capacity on COVID-19
inferredcites →https://doi.org/10.1111/irv.12870openalex-snapshot
ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2
inferredcites →https://doi.org/10.1111/rssc.12435openalex-snapshot
Bayesian Analysis of Tests with Unknown Specificity and Sensitivity
inferredcites →https://doi.org/10.1111/trf.14307openalex-snapshot
Comparison of donor and general population demographics over time: a BEST Collaborative group study
inferredcites →https://doi.org/10.1111/trf.15415openalex-snapshot
Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population‐based study
inferredcites →https://doi.org/10.1126/science.abd7728openalex-snapshot
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
inferredcites →https://doi.org/10.1126/sciimmunol.abe5511openalex-snapshot
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
inferredcites →https://doi.org/10.1136/bmj.b2535openalex-snapshot
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
inferredcites →https://doi.org/10.1136/bmj.m2516openalex-snapshot
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
inferredcites →https://doi.org/10.1136/ebmental-2019-300117openalex-snapshot
How to perform a meta-analysis with R: a practical tutorial
inferredcites →https://doi.org/10.1177/0309133320946302openalex-snapshot
The effect of climate on the spread of the COVID-19 pandemic: A review of findings, and statistical and modelling techniques
inferredcites →https://doi.org/10.1183/13993003.00517-2020openalex-snapshot
No association of COVID-19 transmission with temperature or UV radiation in Chinese cities
inferredcites →https://doi.org/10.1371/journal.pmed.1003346openalex-snapshot
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
inferredcites →https://doi.org/10.1371/journal.pone.0248946openalex-snapshot
Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review
inferredcites →https://doi.org/10.1377/hlthaff.2020.01040openalex-snapshot
Community-Level Factors Associated With Racial And Ethnic Disparities In COVID-19 Rates In Massachusetts
inferredcites →https://doi.org/10.15585/mmwr.mm6933e1openalex-snapshot
Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5–18, 2020 — 22 States, February–June 2020
inferredcites →https://doi.org/10.21203/rs.3.rs-38592/v1openalex-snapshot
The Role of Age Distribution, Time Lag Between Reporting and Death and Healthcare System Capacity in Case Fatality Estimates of COVID-19
inferredcites →https://doi.org/10.3138/jammi-2020-0030openalex-snapshot
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis
inferredcites →https://doi.org/10.3201/eid2606.200320openalex-snapshot
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality
inferredcites →https://doi.org/10.3201/eid2609.201840openalex-snapshot
Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity
inferredcites →https://doi.org/10.3201/eid2701.203611openalex-snapshot
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
inferredcites →https://doi.org/10.53841/bpsicpr.2020.15.2.123openalex-snapshot
Cochrane Handbook for Systematic Reviews of Interventions
inferredcites →https://doi.org/10.7326/m19-0891openalex-snapshot
The Accuracy of Google Translate for Abstracting Data From Non–English-Language Trials for Systematic Reviews
inferredcites →https://doi.org/10.7326/m20-1301openalex-snapshot
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2
inferredcites →https://doi.org/10.7326/m20-2854openalex-snapshot
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2
inferredcites →https://doi.org/10.7554/elife.58785openalex-snapshot
Early analysis of the Australian COVID-19 epidemic

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3965378openalex-extracted
SARS-CoV-2 Antibodies in Children: A One-Year Seroprevalence Study From June 2020 to May 2021 in Germany
inferred← citeshttps://doi.org/10.2139/ssrn.3978650openalex-extracted
Immunogenicity of COVID‑19 Vaccines in Lung Cancer Patients: A SOLID Substudy Interim Analysis
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.24556openalex-snapshot
Africa’s COVID-19 Experience—A Window of Opportunity to Act
inferred← citeshttps://doi.org/10.1002/jmv.27441openalex-snapshot
Changing predominant SARS‐CoV‐2 lineages drives successive COVID‐19 waves in Malaysia, February 2020 to March 2021
inferred← citeshttps://doi.org/10.1002/jrsm.1620openalex-snapshot
SeroTracker‐RoB : A decision rule‐based algorithm for reproducible risk of bias assessment of seroprevalence studies
inferred← citeshttps://doi.org/10.1002/jrsm.1636openalex-snapshot
A real‐world evaluation of the implementation of NLP technology in abstract screening of a systematic review
inferred← citeshttps://doi.org/10.1007/978-1-0716-2395-4_23openalex-snapshot
Evaluation Protocol for SARS-CoV-2 Serological Assays
inferred← citeshttps://doi.org/10.1007/s00103-021-03448-0openalex-snapshot
SARS-CoV-2-Seroprävalenz bei Kindern und Jugendlichen in Deutschland – ein Überblick
inferred← citeshttps://doi.org/10.1007/s10654-024-01169-7openalex-snapshot
Differential risk of healthcare workers versus the general population during outbreak, war and pandemic crises
inferred← citeshttps://doi.org/10.1007/s15010-021-01726-2openalex-snapshot
High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia
inferred← citeshttps://doi.org/10.1007/s15010-021-01731-5openalex-snapshot
Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France
inferred← citeshttps://doi.org/10.1007/s15010-022-01830-xopenalex-snapshot
The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA
inferred← citeshttps://doi.org/10.1007/s15010-023-02011-0openalex-snapshot
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
inferred← citeshttps://doi.org/10.1007/s40615-022-01502-4openalex-snapshot
Disparities in SARS-CoV-2 Infection by Race, Ethnicity, Language, and Social Vulnerability: Evidence from a Citywide Seroprevalence Study in Massachusetts, USA
inferred← citeshttps://doi.org/10.1016/b978-0-443-18769-8.00008-8openalex-snapshot
Population-level differences in COVID-19 prevalence, severity, and clinical outcome
inferred← citeshttps://doi.org/10.1016/j.chaos.2023.113678openalex-snapshot
Endemic oscillations for SARS-CoV-2 Omicron—A SIRS model analysis
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2023.110607openalex-snapshot
Public knowledge of SARS-CoV-2 serological and viral lineage laboratory testing and result interpretation: A GENCOV study cross-sectional survey
inferred← citeshttps://doi.org/10.1016/j.cmi.2021.09.019openalex-snapshot
Update on SARS-CoV-2 seroprevalence: regional and worldwide
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.100770openalex-snapshot
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.eclinm.2022.101786openalex-snapshot
SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.epidem.2022.100581openalex-snapshot
A country-specific model of COVID-19 vaccination coverage needed for herd immunity in adult only or population wide vaccination programme
inferred← citeshttps://doi.org/10.1016/j.epidem.2022.100645openalex-snapshot
Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance
inferred← citeshttps://doi.org/10.1016/j.gaceta.2022.02.008openalex-snapshot
El impacto de la pandemia de COVID-19 sobre la salud. Informe SESPAS 2022
inferred← citeshttps://doi.org/10.1016/j.gloepi.2021.100068openalex-snapshot
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
inferred← citeshttps://doi.org/10.1016/j.heliyon.2022.e10270openalex-snapshot
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e19547openalex-snapshot
Rapid increase of SARS-CoV-2 seroprevalence during the second half of the COVID-19 pandemic year 2020 in the adult urban Albanian population
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e24184openalex-snapshot
Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020–2021
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.04.015openalex-snapshot
Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.12.336openalex-snapshot
SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.12.353openalex-snapshot
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ijid.2022.03.021openalex-snapshot
SARS-CoV-2 seroprevalence and associated risk factors in periurban Zambia: a population-based study
inferred← citeshttps://doi.org/10.1016/j.ijid.2022.03.043openalex-snapshot
Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste
inferred← citeshttps://doi.org/10.1016/j.ijid.2022.12.009openalex-snapshot
SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.ijmmb.2024.100700openalex-snapshot
Use of dried blood spots in the detection of coronavirus disease 2019 (COVID-19): A systematic review
inferred← citeshttps://doi.org/10.1016/j.ijregi.2022.06.007openalex-snapshot
Anti SARS-CoV-2 seroprevalence in Zanzibar in 2021 before the Omicron wave
inferred← citeshttps://doi.org/10.1016/j.ijregi.2022.07.010openalex-snapshot
Systematic literature review of SARS-CoV-2 seroprevalence surveys in Canada through April 2021
inferred← citeshttps://doi.org/10.1016/j.jim.2023.113440openalex-snapshot
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
inferred← citeshttps://doi.org/10.1016/j.jiph.2023.04.016openalex-snapshot
Population-based sero-epidemiological investigation of SARS-CoV-2 infection in Somalia
inferred← citeshttps://doi.org/10.1016/j.jmh.2025.100392openalex-snapshot
Essential worker status, gender, and migration background disparities in COVID-19: An intersectional approach
inferred← citeshttps://doi.org/10.1016/j.lungcan.2023.107323openalex-snapshot
Immunogenicity of COVID-19 vaccines in lung cancer patients
inferred← citeshttps://doi.org/10.1016/j.puhe.2021.11.013openalex-snapshot
SARS-CoV-2 serosurvey among adults involved in healthcare and health research in Guinea-Bissau, West Africa
inferred← citeshttps://doi.org/10.1016/j.tim.2024.12.006openalex-snapshot
Strengthening serological studies: the need for greater geographical diversity, biobanking, and data-accessibility
inferred← citeshttps://doi.org/10.1016/j.tmrv.2021.07.003openalex-snapshot
Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.02.017openalex-snapshot
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.127310openalex-snapshot
COVID-19 serological survey utilizing antenatal serum samples in British Columbia
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)02835-xopenalex-snapshot
COVID-19 vaccine strategies must focus on severe disease and global equity
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)01896-7openalex-snapshot
Reconsidering the COVID-19 vaccine strategy in West and Central Africa
inferred← citeshttps://doi.org/10.1016/s2666-5247(22)00114-8openalex-snapshot
Estimating typhoid incidence from community-based serosurveys: a multicohort study
inferred← citeshttps://doi.org/10.1017/s0021932023000068openalex-snapshot
COVID-19 mortality among Jews in 2020: a global overview and lessons taught about the Jewish longevity advantage
inferred← citeshttps://doi.org/10.1017/s0950268821000972openalex-snapshot
Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
inferred← citeshttps://doi.org/10.1017/s0950268821002405openalex-snapshot
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
inferred← citeshttps://doi.org/10.1017/s0950268823000481openalex-snapshot
Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina
inferred← citeshttps://doi.org/10.1017/s0950268824001353openalex-snapshot
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India
inferred← citeshttps://doi.org/10.1017/s0950268824001389openalex-snapshot
Measles and rubella seroprevalence in adults using residual blood samples from health facilities and household serosurveys in Palghar District, Maharashtra, India, 2018 – 2019
inferred← citeshttps://doi.org/10.1038/s41423-024-01127-zopenalex-snapshot
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1038/s41467-022-28232-9openalex-snapshot
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico
inferred← citeshttps://doi.org/10.1038/s41467-022-30482-6openalex-snapshot
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
inferred← citeshttps://doi.org/10.1038/s41597-022-01830-4openalex-snapshot
COVID-19 SeroHub, an online repository of SARS-CoV-2 seroprevalence studies in the United States
inferred← citeshttps://doi.org/10.1038/s41598-022-23821-6openalex-snapshot
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020
inferred← citeshttps://doi.org/10.1038/s41598-023-32441-7openalex-snapshot
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
inferred← citeshttps://doi.org/10.1038/s41598-025-91529-4openalex-snapshot
Seroprevalence of SARS-CoV-2 antibodies among oral health care workers with natural seroconversion: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1080/10408363.2023.2254390openalex-snapshot
Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics
inferred← citeshttps://doi.org/10.1080/20477724.2022.2121366openalex-snapshot
Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil
inferred← citeshttps://doi.org/10.1080/23744235.2021.2025421openalex-snapshot
SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)
inferred← citeshttps://doi.org/10.1080/23744235.2022.2035429openalex-snapshot
Incidence of SARS-CoV-2 infection in a cohort of workers from the University of Porto, Portugal
inferred← citeshttps://doi.org/10.1093/cid/ciac516openalex-snapshot
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July–August 2020
inferred← citeshttps://doi.org/10.1093/cid/ciaf342openalex-snapshot
SARS-CoV-2 Seroprevalence, Illness Recall, and Work Absenteeism Among Healthcare Workers: A Facility-Based Cross-Sectional Study in the Philippines, 2021
inferred← citeshttps://doi.org/10.1093/ije/dyab110openalex-snapshot
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
inferred← citeshttps://doi.org/10.1093/ije/dyac178openalex-snapshot
Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data
inferred← citeshttps://doi.org/10.1093/ije/dyae078openalex-snapshot
Temporal trends in disparities in COVID-19 seropositivity among Canadian blood donors
inferred← citeshttps://doi.org/10.1093/infdis/jiab517openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in Blood Donor Populations
inferred← citeshttps://doi.org/10.1093/occmed/kqad003openalex-snapshot
SARS-CoV-2 seroprevalence in workers from a Colombian University Hospital
inferred← citeshttps://doi.org/10.1093/ofid/ofab632openalex-snapshot
Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
inferred← citeshttps://doi.org/10.1093/ofid/ofac152openalex-snapshot
High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
inferred← citeshttps://doi.org/10.1093/ofid/ofag197openalex-snapshot
Estimating Enteric Fever Seroincidence in Bangladesh Using Rapid Serosurveys
inferred← citeshttps://doi.org/10.1097/inf.0000000000003916openalex-snapshot
Investigating the Possible Reasons for the Low Reported Morbidity and Mortality of COVID-19 in African Countries: An Integrative Review
inferred← citeshttps://doi.org/10.1101/2021.03.15.21253609openalex-snapshot
Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogotá Colombia
inferred← citeshttps://doi.org/10.1101/2021.06.29.21259730openalex-snapshot
Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021
inferred← citeshttps://doi.org/10.1101/2021.11.22.21266711openalex-snapshot
Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
inferred← citeshttps://doi.org/10.1101/2021.12.02.21266897openalex-snapshot
Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic review
inferred← citeshttps://doi.org/10.1101/2021.12.08.21267162openalex-snapshot
Evaluating the number of unvaccinated people needed to exclude to prevent SARS-CoV-2 transmissions
inferred← citeshttps://doi.org/10.1101/2022.02.07.22270634openalex-snapshot
Deploying wearable sensors for pandemic mitigation
inferred← citeshttps://doi.org/10.1101/2022.02.22.22270907openalex-snapshot
SARS-CoV-2 seroprevalence, vaccination, and hesitancy in agricultural workers in Guatemala
inferred← citeshttps://doi.org/10.1101/2022.06.07.22276128openalex-snapshot
Seroprevalence of SARS-CoV-2 and risk factors in Bantul Regency, Yogyakarta, Indonesia
inferred← citeshttps://doi.org/10.1101/2022.07.21.22277881openalex-snapshot
Prospective investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic
inferred← citeshttps://doi.org/10.1101/2023.08.23.23294474openalex-snapshot
COVID-19 self-testing: Countries accelerating policies ahead of WHO guidelines during pandemics: A Global Survey
inferred← citeshttps://doi.org/10.1101/2023.08.29.23293775openalex-snapshot
Estimating seroprevalence of SARS-CoV-2 infection after a highly contagious Omicron outbreak: A cross sectional study in a university setting
inferred← citeshttps://doi.org/10.1101/2023.09.19.23295776openalex-snapshot
Analysis of SARS-CoV-2 Ig seroprevalence in Northern Ireland
inferred← citeshttps://doi.org/10.1101/2024.03.08.24303942openalex-snapshot
Prevalence and seroprevalence of COVID-19 infection among older people: A scoping review based on population-based studies in 2020-2022
inferred← citeshttps://doi.org/10.1101/2024.03.13.24304208openalex-snapshot
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: a descriptive cross-sectional study
inferred← citeshttps://doi.org/10.1101/2024.04.23.24305972openalex-snapshot
Assessing Seroprevalence of SARS-CoV-2 Antibodies Among US College Students after School Reopening
inferred← citeshttps://doi.org/10.1101/2025.06.13.25329541openalex-snapshot
Automation of Systematic Reviews with Large Language Models
inferred← citeshttps://doi.org/10.1101/2025.06.29.25330529openalex-snapshot
Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and reversion by time since infection, test, age and disease severity
inferred← citeshttps://doi.org/10.1111/cdoe.12827openalex-snapshot
Prevalence of SARS‐CoV ‐2 infection among oral health care workers worldwide: A meta‐analysis
inferred← citeshttps://doi.org/10.1111/eci.13554openalex-snapshot
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
inferred← citeshttps://doi.org/10.1111/eci.13678openalex-snapshot
COVID‐19 vaccination in children and university students
inferred← citeshttps://doi.org/10.1111/eci.13782openalex-snapshot
The end of the COVID‐19 pandemic
inferred← citeshttps://doi.org/10.1111/irv.12870openalex-snapshot
ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2
inferred← citeshttps://doi.org/10.1111/irv.13216openalex-snapshot
The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation
inferred← citeshttps://doi.org/10.1111/irv.13267openalex-snapshot
Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020
inferred← citeshttps://doi.org/10.1111/irv.13283openalex-snapshot
Adherence of SARS‐CoV‐2 Seroepidemiologic Studies to the ROSES‐S Reporting Guideline During the COVID‐19 Pandemic
inferred← citeshttps://doi.org/10.1111/irv.70004openalex-snapshot
Prevalence of SARS‐CoV‐2 Antibodies in Kosovo‐Wide Population‐Based Seroepidemiological Study
inferred← citeshttps://doi.org/10.1111/jep.13813openalex-snapshot
Estimating the risk reduction of isolation on COVID‐19 nonhousehold transmission and severe/critical illness in nonimmune individuals: September to November 2021
inferred← citeshttps://doi.org/10.1111/joim.13637openalex-snapshot
SARS‐CoV‐2 antibody dynamics over time and risk factors associated with infection and long COVID‐19 symptoms in large working environments
inferred← citeshttps://doi.org/10.1111/trf.16943openalex-snapshot
How do we …form and coordinate a national serosurvey of SARS‐CoV ‐2 within the blood collection industry?
inferred← citeshttps://doi.org/10.1111/vox.13545openalex-snapshot
Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID ‐19 serological assays as a proof of concept
inferred← citeshttps://doi.org/10.1128/spectrum.03234-22openalex-snapshot
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications
inferred← citeshttps://doi.org/10.1136/bmjgh-2022-008793openalex-snapshot
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
inferred← citeshttps://doi.org/10.1136/bmjopen-2021-057846openalex-snapshot
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-062567openalex-snapshot
Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-063771openalex-snapshot
Occupation and SARS-CoV-2 seroprevalence studies: a systematic review
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-064240openalex-snapshot
Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January–December 2020
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-068258openalex-snapshot
Investigation of SARS-CoV-2 seroprevalence in relation to natural infection and vaccination between October 2020 and September 2021 in the Czech Republic: a prospective national cohort study
inferred← citeshttps://doi.org/10.1136/jcp-2022-208171openalex-snapshot
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology
inferred← citeshttps://doi.org/10.11604/pamj.2023.45.22.36513openalex-snapshot
Seroprevalence of SARS-CoV-2 immunoglobulin G antibody during COVID-19 pandemic in Fayoum District, Egypt: a community-based pilot survey
inferred← citeshttps://doi.org/10.11606/s1518-8787.2023057004782openalex-snapshot
Soroprevalência de anticorpos do vírus SARS-CoV-2 em escolares no município de São Paulo, 2020
inferred← citeshttps://doi.org/10.1177/10105395221115147openalex-snapshot
Seropositivity Against SARS-Cov-2 Infection in India: A Systematic Review and Meta Analysis
inferred← citeshttps://doi.org/10.1186/s12879-021-05864-8openalex-snapshot
Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study
inferred← citeshttps://doi.org/10.1186/s12879-022-07031-zopenalex-snapshot
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
inferred← citeshttps://doi.org/10.1186/s12879-023-08361-2openalex-snapshot
Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
inferred← citeshttps://doi.org/10.1186/s12879-024-09013-9openalex-snapshot
Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada
inferred← citeshttps://doi.org/10.1186/s12879-026-13543-9openalex-snapshot
Characteristics of COVID-19 cases and factors associated with disease severity in Lao People’s Democratic Republic: a nationwide study
inferred← citeshttps://doi.org/10.1186/s12889-022-14381-5openalex-snapshot
Pre-vaccination RT-PCR negative contacts in workplace settings show high, SARS COV-2 neutralizing antibody levels
inferred← citeshttps://doi.org/10.1186/s12889-022-14794-2openalex-snapshot
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
inferred← citeshttps://doi.org/10.1186/s12889-023-17239-6openalex-snapshot
Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020–February 2022
inferred← citeshttps://doi.org/10.1186/s12889-024-20274-6openalex-snapshot
Predictors of seropositivity to SARS-CoV-2 among employees at a large urban medical center
inferred← citeshttps://doi.org/10.1186/s12889-024-20364-5openalex-snapshot
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s12912-023-01356-zopenalex-snapshot
The impact of the COVID-19 pandemic on the health and working conditions of nurses and its implications for policies: a cross-sectional study in Slovakia
inferred← citeshttps://doi.org/10.1186/s12961-023-00973-zopenalex-snapshot
A framework for seroepidemiologic investigations in future pandemics: insights from an evaluation of WHO’s Unity Studies initiative
inferred← citeshttps://doi.org/10.1186/s40001-022-00710-2openalex-snapshot
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s41182-022-00468-7openalex-snapshot
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis
inferred← citeshttps://doi.org/10.1257/aeri.20230195openalex-snapshot
Nonrepresentativeness in Population Health Research: Evidence from a COVID-19 Antibody Study
inferred← citeshttps://doi.org/10.12688/gatesopenres.14684.1openalex-snapshot
Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021
inferred← citeshttps://doi.org/10.12688/wellcomeopenres.16701.1openalex-snapshot
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies
inferred← citeshttps://doi.org/10.12688/wellcomeopenres.16701.2openalex-snapshot
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies
inferred← citeshttps://doi.org/10.12688/wellcomeopenres.16701.3openalex-snapshot
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studies
inferred← citeshttps://doi.org/10.1371/journal.pdig.0000100openalex-snapshot
Deploying wearable sensors for pandemic mitigation: A counterfactual modelling study of Canada’s second COVID-19 wave
inferred← citeshttps://doi.org/10.1371/journal.pgph.0000363openalex-snapshot
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey
inferred← citeshttps://doi.org/10.1371/journal.pgph.0000549openalex-snapshot
Nigeria healthcare worker SARS-CoV-2 serology study: Results from a prospective, longitudinal cohort
inferred← citeshttps://doi.org/10.1371/journal.pgph.0000658openalex-snapshot
U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022
inferred← citeshttps://doi.org/10.1371/journal.pgph.0000698openalex-snapshot
Seroprevalence of SARS-CoV-2 and risk factors in Bantul Regency in March-April 2021, Yogyakarta, Indonesia
inferred← citeshttps://doi.org/10.1371/journal.pgph.0000727openalex-snapshot
Seroprevalence of SARS-CoV-2 antibodies in Bali Province: Indonesia shows underdetection of COVID-19 cases by routine surveillance
inferred← citeshttps://doi.org/10.1371/journal.pgph.0002369openalex-snapshot
COVID-19 self-testing: Countries accelerating policies ahead of WHO guidelines during pandemics, a global consultation
inferred← citeshttps://doi.org/10.1371/journal.pgph.0002380openalex-snapshot
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals
inferred← citeshttps://doi.org/10.1371/journal.pgph.0003831openalex-snapshot
Assessing COVID-19 seroprevalence and vaccine uptake among women of reproductive-age in Zanzibar’s archipelago
inferred← citeshttps://doi.org/10.1371/journal.pgph.0003893openalex-snapshot
The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting
inferred← citeshttps://doi.org/10.1371/journal.pmed.1004107openalex-snapshot
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
inferred← citeshttps://doi.org/10.1371/journal.pone.0261931openalex-snapshot
Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia
inferred← citeshttps://doi.org/10.1371/journal.pone.0267725openalex-snapshot
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV
inferred← citeshttps://doi.org/10.1371/journal.pone.0269104openalex-snapshot
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
inferred← citeshttps://doi.org/10.1371/journal.pone.0273482openalex-snapshot
SARS-CoV-2 infections in infants in Haiti 2020–2021; evidence from a seroepidemiological cohort
inferred← citeshttps://doi.org/10.1371/journal.pone.0279660openalex-snapshot
Demographic, social, and behavioral correlates of SARS-CoV-2 seropositivity in a representative, population-based study of Minnesota residents
inferred← citeshttps://doi.org/10.1371/journal.pone.0283197openalex-snapshot
COVID-19: Establishing, implementing and assessment safety strategy, descriptive interventional study
inferred← citeshttps://doi.org/10.1371/journal.pone.0286014openalex-snapshot
Feasibility of self-organized blood sample collection in adults for study purposes in a primary care setting
inferred← citeshttps://doi.org/10.1371/journal.pone.0292440openalex-snapshot
Seroprevalence of SARS-CoV-2 IgG among healthcare workers in Lagos, Nigeria
inferred← citeshttps://doi.org/10.1371/journal.pone.0305850openalex-snapshot
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study
inferred← citeshttps://doi.org/10.1371/journal.pone.0311196openalex-snapshot
Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study
inferred← citeshttps://doi.org/10.1371/journal.pone.0328144openalex-snapshot
Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity
inferred← citeshttps://doi.org/10.1371/journal.pone.0334627openalex-snapshot
Two-stage cluster sampling to assess SARS-CoV-2 seroprevalence without pre-enumeration: An example from Madagascar
inferred← citeshttps://doi.org/10.1371/journal.pone.0336239openalex-snapshot
Nationwide seroprevalence of SARS-CoV-2 during the COVID-19 pandemic and prepandemic periods in Lao PDR
inferred← citeshttps://doi.org/10.1371/journal.pone.0348281openalex-snapshot
Serological responses to SARS-CoV-2 in urban and rural Ghana: Antibody waning and implications for long-term population immunity
inferred← citeshttps://doi.org/10.14361/9783839467893openalex-snapshot
Universität in der Pandemie / L'Université en temps de pandémie
inferred← citeshttps://doi.org/10.14361/9783839467893-003openalex-snapshot
Covid-19 in Deutschland und Frankreich
inferred← citeshttps://doi.org/10.1515/9783839467893openalex-snapshot
Universität in der Pandemie / L'Université en temps de pandémie
inferred← citeshttps://doi.org/10.1515/9783839467893-003openalex-snapshot
Covid-19 in Deutschland und Frankreich
inferred← citeshttps://doi.org/10.15517/psm.v21i1.53436openalex-snapshot
Seroprevalence of antibodies against SARS-Cov-2 among adults from a municipality in the Buenos Aires suburbs, República Argentina
inferred← citeshttps://doi.org/10.1556/030.2022.01706openalex-snapshot
Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: A cross-sectional study
inferred← citeshttps://doi.org/10.18257/raccefyn.1590openalex-snapshot
Serorreactividad al SARS-CoV-2 en trabajadores de un campus universitario en Bogotá, Colombia
inferred← citeshttps://doi.org/10.18502/ijm.v14i2.9178openalex-snapshot
Seroprevalence of SARS-COV-2 antibodies among health-care workers exposed to COVID-19 patients in a large reference hospital, Iran
inferred← citeshttps://doi.org/10.18569/tempus.v16i3.3065openalex-snapshot
A área profissional está associada à soroconversão para SARS-CoV-2 entre os profissionais do SESC-DF? Um estudo transversal
inferred← citeshttps://doi.org/10.20944/preprints202403.0923.v1openalex-snapshot
Seroprevalence of Anti-SARS-Cov-2 Antibodies among Patients Visiting Hospital-Based Sentinel Sites in the Rift Valley Region, Kenya
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1769582/v1openalex-snapshot
SARS-CoV-2 antibody seroprevalence in Togo, May-June 2021: a cross-sectional, nationally representative, age-stratified serosurvey
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1870665/v1openalex-snapshot
Prevalence of Immunoglobulin (G (IgG) and M (IgM)) Against SARS-COV-2 and risk factors for positivity among Students at tertiary education institution, Malawi
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8702917/v1openalex-snapshot
SARS-CoV-2 seroepidemiology, infection prevention and control practices, and occupational risks during healthcare worker reduction: a repeated cross-sectional study in Côte d'Ivoire, 2022
inferred← citeshttps://doi.org/10.2147/idr.s383491openalex-snapshot
Seroprevalence of SARS-CoV-2 Antibodies in Denmark: Results of Two Nationwide Population-Based Surveys, February and May 2021
inferred← citeshttps://doi.org/10.24321/2349.7181.202215openalex-snapshot
Seroprevalence of COVID-19 Antibodies among Patients with Haemophilia
inferred← citeshttps://doi.org/10.25646/7853openalex-snapshot
Seroepidemiological study on the spread of SARS-CoV-2 in Germany:
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2021.26.48.2101040openalex-snapshot
Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
inferred← citeshttps://doi.org/10.3138/jammi-2023-0017openalex-snapshot
SARS-CoV-2 seroprevalence in Nova Scotia blood donors
inferred← citeshttps://doi.org/10.3201/eid2805.211951openalex-snapshot
SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan
inferred← citeshttps://doi.org/10.3201/eid2813.221193openalex-snapshot
Building on Capacity Established through US Centers for Disease Control and Prevention Global Health Programs to Respond to COVID-19, Cameroon
inferred← citeshttps://doi.org/10.3201/eid3011.240043openalex-snapshot
Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021–February 2022
inferred← citeshttps://doi.org/10.3386/w30880openalex-snapshot
Representation and Hesitancy in Population Health Research: Evidence from a COVID-19 Antibody Study
inferred← citeshttps://doi.org/10.3389/fimmu.2021.633184openalex-snapshot
Antibody Responses in COVID-19: A Review
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1242536openalex-snapshot
Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.3389/fpubh.2022.874252openalex-snapshot
Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland
inferred← citeshttps://doi.org/10.3389/fpubh.2022.989337openalex-snapshot
Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak
inferred← citeshttps://doi.org/10.3389/fpubh.2023.1238502openalex-snapshot
Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022
inferred← citeshttps://doi.org/10.3389/fpubh.2024.1326125openalex-snapshot
Serological screening in a large-scale municipal survey in Cascais, Portugal, during the first waves of the COVID-19 pandemic: lessons for future pandemic preparedness efforts
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1642407openalex-snapshot
Social inequalities in SARS-CoV-2 infection in high income countries: highlighting the need for an intersectional perspective in quantitative research
inferred← citeshttps://doi.org/10.3389/ijph.2026.1608670openalex-snapshot
Work-Related Exposures Mediate Occupational Class Disparities in SARS-CoV-2 Infection in France
inferred← citeshttps://doi.org/10.3390/diagnostics12020295openalex-snapshot
SARS-CoV-2 Sero-Surveillance in Greece: Evolution over Time and Epidemiological Attributes during the Pre-Vaccination Pandemic Era
inferred← citeshttps://doi.org/10.3390/diagnostics12040971openalex-snapshot
COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
inferred← citeshttps://doi.org/10.3390/ijerph18063188openalex-snapshot
Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland
inferred← citeshttps://doi.org/10.3390/ijerph18126680openalex-snapshot
Nine Months of COVID-19 Pandemic in Europe: A Comparative Time Series Analysis of Cases and Fatalities in 35 Countries
inferred← citeshttps://doi.org/10.3390/ijerph19042263openalex-snapshot
Seropositivity of SARS-CoV-2 in the Population of Kazakhstan: A Nationwide Laboratory-Based Surveillance
inferred← citeshttps://doi.org/10.3390/ijerph19127257openalex-snapshot
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/ijerph19137882openalex-snapshot
Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy
inferred← citeshttps://doi.org/10.3390/ijerph191811629openalex-snapshot
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review
inferred← citeshttps://doi.org/10.3390/ijerph20010245openalex-snapshot
COVID and Gender: A Narrative Review of the Asia-Pacific Region
showing the first 200 of 245
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.